• WASHINGTON - LambdaVision, a company that has used microgravity experiments on the International Space Station to develop an artificial retina, has booked space on a planned commercial successor. • LambdaVision announced Feb. • 24 that it reserved payload space on Starlab, the commercial space station under development by the Starlab Space joint venture. • The company did not disclose the amount of payload space reserved or the value of the contract. • Connecticut-based LambdaVision has worked for several years to develop artificial retinas, testing the production of protein thin films in microgravity through experiments flown on the ISS. • The microgravity environment enables the creation of layers of thin films needed to produce the artificial retinas, which the company plans to test in patients with advanced retinitis pigmentosa.

Article Summaries:

  • WASHINGTON - LambdaVision, a company that has used microgravity experiments on the International Space Station to develop an artificial retina, has booked space on a planned commercial successor. LambdaVision announced Feb. 24 that it reserved payload space on Starlab, the commercial space station under development by the Starlab Space joint venture. The company did not disclose the amount of payload space reserved or the value of the contract. Connecticut-based LambdaVision has worked for several years to develop artificial retinas, testing the production of protein thin films in microgravity

Sources: